13d
Arrowhead Stock Has Skyrocketed 290% in One Year, and One Fund Trimmed Its Holdings by $4 Million
This biotech firm develops RNAi therapeutics for rare and serious diseases, leveraging clinical partnerships to advance its ...
Why Arrowhead Pharmaceuticals Is Drawing Investor Attention Now Arrowhead Pharmaceuticals (ARWR) is back on many watchlists after a sharp total return over the past 3 months and the past year. This ...
Learn more about whether Arrowhead Pharmaceuticals, Inc. or BeOne Medicines AG is a better investment based on AAII's A+ ...
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results